HSP90AA1 and hepatocellular carcinoma: In a clinical study of patients with hepatocellular carcinoma, plasma HSP90α has been found to be of diagnostic value for early hepatocellular carcinoma, and the combination of AFP can improve the diagnostic efficiency (22).